Gunther Kretschmar
Boehringer Ingelheim (Germany)(DE)
Publications by Year
Research Areas
Chronic Obstructive Pulmonary Disease (COPD) Research, Pulmonary Hypertension Research and Treatments, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Phagocytosis and Immune Regulation, Medical and Biological Ozone Research
Most-Cited Works
- → Decreasing Cardiac Chamber Sizes and Associated Heart Dysfunction in COPD(2010)277 cited
- → The Metabolic Syndrome in Patients With Chronic Bronchitis and COPD(2009)264 cited
- → Randomized clinical trial of Appendicitis Inflammatory Response score-based management of patients with suspected appendicitis(2017)90 cited
- → Pharmacokinetics of Nintedanib in Subjects With Hepatic Impairment(2017)30 cited
- → Efficacy of the pan-selectin antagonist Bimosiamose on ozone-induced airway inflammation in healthy subjects – A double blind, randomized, placebo-controlled, cross-over clinical trial(2011)28 cited
- → Pharmakokinetik, Sicherheit und Aktivität von Formoterol verabreicht über den Genuair Inhalator® mit und ohne Aclidinium-Bromid(2011)5 cited
- → Safety and Tolerability of Escalating Doses of Microencapsulated Grass (Phleum Pratense) Pollen Extract (MGPE) for Oral Immunotherapy (OIT) in Grass Pollen Allergic Subjects(2008)2 cited
- → Physical Activity in Patients with Chronic Obstructive Pulmonary Disease.(2009)2 cited
- → Decreasing Heart Size And Associated Heart Dysfunction In COPD – Role Of Hyperinflation(2010)1 cited
- → 650 Neoadjuvant ezabenlimab or pembrolizumab in combination with an anti-SIRPα antibody in resectable colorectal cancer(2023)